ASO Visual Abstract: TRIM37 Expression is Associated with Immune Suppression, Poor Response to Neoadjuvant Chemotherapy, and Worse Survival in ER-Positive/HER2-Negative Breast Cancer. - Tsuchida J; Wu R; Nagahashi M; Ebos JML; Ishikawa T; Shimoda M; Wakai T; Takabe K (Annals of surgical oncology, 2026)